Considering the dynamic advancements in molecular research concerning ameloblastoma, the present study endeavors to define the prevalence of the BRAF V600E mutation in a significant sample of ameloblastomas derived from Latin American centers and to explore its potential associations with the histological variants of this odontogenic neoplasm. This evidence concerns the gene BRAF and ameloblastoma.